Harnessing the Full Potential of Frontline Immunotherapy in Advanced NSCLC: Proceedings from a Clinical Olympics℠

Program Overview

The advent of frontline immunotherapy has significantly extended survival for certain patients with metastatic non-small cell lung cancer (NSCLC). As the field rapidly evolves, clinicians are challenged to navigate an increasingly complex therapeutic landscape. In this clinically relevant, high-level activity, Dr. Jared Weiss, Prof. Aleš Ryška, and Dr. Mihaela Aldea provide privileged insights into the nuances of biomarker testing, optimal regimen selection, and management of immune-related adverse events.

Credit Expired
1.0 CE Credit(s)
Expires: September 28, 2023

Target Audience

Medical oncology and pulmonology clinicians managing patients with advanced NSCLC.

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Utilize molecular testing in patients with advanced non-small cell lung cancer (NSCLC) as a guide for frontline treatment selection
  • Select optimal frontline immune checkpoint inhibitor regimens in appropriate patients with advanced NSCLC
  • Manage potential immune-related adverse events in patients with advanced NSCLC receiving first-line immunotherapy

Activity Faculty

Jared M. Weiss, MD

Jared M. Weiss, MD

Professor, Medicine
Lineberger Comprehensive Cancer Center
The University of North Carolina at Chapel Hill
Chapel Hill, United States

Ales Ryska_Faculty Headshot_1200x1500

Prof. MUDr. Aleš Ryška, MD, PhD

Head, Fingerland Department of Pathology
Charles University Medical Faculty
Hradec Králové University Hospital
Prague, Czech Republic

Aldea_Mihaela@2x

Mihaela Aldea, MD, PhD

Associate Professor, Medical Oncology
Paris-Saclay University
Gustave Roussy
Villejuif, France

Supporter Statement

Provider Statement

Disclosure of Financial Relationships

Faculty

Planners and Managers

Provider Statement 

Provided by RMEI Medical Education, LLC 

Statement of Commercial Support 

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi. 

Disclosure of Financial Relationships 

RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy. 

Faculty 

Jared M. Weiss, MD,  has relevant financial relationships with AstraZeneca, Boehringer Ingelheim, Eli Lilly, G1 Therapeutics, Merck, Mirati, Sumitomo Dainippon Pharma (Researcher); AbbVie, AstraZeneca, Azira, Eli Lilly, EMD Serono, G1 Therapeutics, Genentech, Genmab, Jazz Pharmaceuticals, Jounce Therapeutics, Nanobiotix, Pfizer, Regeneron, Sumitomo Dainippon Pharma (Consultant); Achilles, En Fuego Therapeutics, Lyell, Nuvalent, Vesselon (Stock/Stockholder). 

Prof. MUDr. Aleš Ryška, MD, PhD,  has relevant financial relationships with Amgen, Elphogene, Lilly, MSD, Roche (Advisor); Amgen, Bristol-Myers Squibb, Gilead, MSD, Roche (Speaker/Speaker’s Bureau); Roche, Sanofi (Other: Travel Support). 

Mihaela Aldea, MD, PhD,  has a relevant financial relationship with Sandoz (Other: Travel/Expenses). 

All of the relevant financial relationships listed for these individuals have been mitigated according to RMEI policies. 

Planners and Managers 
RMEI Medical Education, LLC planners and managers have no relevant financial relationship(s) with ineligible companies to disclose. 

Joint Accreditation Statement 

In support of improving patient care, RMEI Medical Education, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

 

Designation of Credit 

Physician Continuing Medical Education 
RMEI Medical Education, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Continuing Nursing Education 
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour(s). 

Instructions for Receiving Credit 

In order to receive credit, participants must review the activity content and successfully complete both the post-test and evaluation. A statement of credit will be available to print immediately. You must score 80% or higher on the post-test to receive credit for this activity. If you have questions about this activity, please contact RMEI at [email protected]. 

Users must: 

  • Read the learning objectives and faculty disclosures 
  • Participate in the activity 
  • Complete the activity evaluation and attest to credit

 

There is no fee to participate. 

Your Feedback is Important! 

COMPLETE THE EVALUATION FORM AND YOU WILL BE ENTERED INTO A DRAWING
FOR A $100* AMAZON GIFT CARD!
 
*The expense for this gift card is solely funded by RMEI Medical Education, LLC. 
No supporter funding was used for the expense of this gift card. 

Rules and Regulations 
This sweepstakes is managed by RMEI Medical Education, LLC (RMEI), a jointly accredited provider. The winner will be selected via automated random drawing on a quarterly basis from among all eligible entries and notified through the contact information provided. In accordance with our privacy policy, we do not share your information with any third parties. By entering the sweepstakes, you grant RMEI permission to use your e-mail address to reach you for notification and prize fulfillment. Only individuals who complete the evaluation forms and provide contact information will be eligible to win. Open to those who have a US postal address and who are 18 years or older. Only one prize per person and per household will be awarded. The prize will be a $100 Amazon gift card. 

Disclosure of Unlabeled Use 

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Disclaimer Statement 

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

Resources 

Method of Participation and Request for Credit

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Disclaimer Statement

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

Copyright Statement

© Copyright 2024. All rights reserved. Developed and managed by RMEI Medical Education, LLC. Laurel Office Plaza | 101 Laurel Road, Suite 200 | Voorhees, NJ 08043 | www.RMEI.com | (866) 770-RMEI

Subscribe

Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources